INS and Insulin resistance: Studies have demonstrated that FMT from lean donors to individuals with metabolic syndrome can improve insulin sensitivity, highlighting the potential of gut microbiota manipulation as a therapeutic strategy for insulin resistance (Kootte et al., 2017).